Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.
Publication
, Journal Article
Caram, MEV; Skolarus, TA; Cooney, KA
Published in: Eur Urol
August 2016
Prostate-specific antigen (PSA) is frequently used in isolation to guide treatment decisions in men with recurrent prostate cancer, a practice discouraged by prostate cancer working groups and guidelines. Instead, PSA should be used with imaging and other factors to make treatment decisions.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
August 2016
Volume
70
Issue
2
Start / End Page
209 / 210
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Patient Care Management
- Male
- Humans
- Clinical Decision-Making
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Caram, M. E. V., Skolarus, T. A., & Cooney, K. A. (2016). Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. Eur Urol, 70(2), 209–210. https://doi.org/10.1016/j.eururo.2015.12.045
Caram, Megan E. V., Ted A. Skolarus, and Kathleen A. Cooney. “Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.” Eur Urol 70, no. 2 (August 2016): 209–10. https://doi.org/10.1016/j.eururo.2015.12.045.
Caram MEV, Skolarus TA, Cooney KA. Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. Eur Urol. 2016 Aug;70(2):209–10.
Caram, Megan E. V., et al. “Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.” Eur Urol, vol. 70, no. 2, Aug. 2016, pp. 209–10. Pubmed, doi:10.1016/j.eururo.2015.12.045.
Caram MEV, Skolarus TA, Cooney KA. Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis. Eur Urol. 2016 Aug;70(2):209–210.
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
August 2016
Volume
70
Issue
2
Start / End Page
209 / 210
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Patient Care Management
- Male
- Humans
- Clinical Decision-Making
- 3202 Clinical sciences
- 1103 Clinical Sciences